1/64
Looks like no tags are added yet.
Case: 58M with T2DM, HTN, dyslipidemia, ischemic stroke 2023, A1c 7.8%, LDL 88. Which is the best next agent?
A) Actos
B) Ozempic
C) Januvia
D) Glipizide
B) He has ASCVD and A1c above goal, so a GLP-1 RA with proven CV benefit fits. Trulicity, Mounjaro, Farxiga, Jardiance, and Invokana are also reasonable per Dr. Lewis. Actos lacks CV benefit. Januvia is weak for A1c with no CV benefit.
Case: 68F with T2DM, HTN, dyslipidemia, CKD stage 2, current smoker, no documented ASCVD. Which is appropriate?
A) Aspirin is never recommended for primary prevention
B) Aspirin 75-162 mg daily for all DM patients
C) Aspirin 81 mg daily after weighing bleeding risk
D) Clopidogrel for primary prevention
C) She is under 70 with major risk factors, and CKD stages 1-3 count as a major risk factor. Primary prevention is a benefit-risk decision.
Case: 58F with DM, BP 142/81. What is the BP goal per ADA?
A) <140/90
B) <130/80
C) <150/90
D) <120/80
B) ADA and ACC/AHA agree. Dr. Lewis said JNC-8 (<140/90) is outdated.
Case: 62M with DM, no albuminuria or CAD, BPs 168/94 and 160/92. Which initial regimen fits?
A) Lifestyle changes alone
B) Lisinopril alone
C) Lisinopril and telmisartan
D) Olmesartan and amlodipine
D) Initial SBP ≥160 or DBP ≥100 means start two agents. Lisinopril with telmisartan is dual RAAS blockade and should be avoided.
Case: 67F with DM on rosuvastatin 40 mg, LDL 140, TG 201. What is the next step?
A) Switch to atorvastatin 80 mg
B) Add niacin
C) Add ezetimibe
D) Add gemfibrozil
C) LDL is above goal, and ezetimibe is the simplest add-on. Rosuvastatin 40 and atorvastatin 80 are both high intensity, so switching does not help. Niacin is rarely used now.
Case: 68F with DM, LDL controlled on statin, TG 250 mg/dL. Which drug reduces CV risk?
A) Icosapent ethyl (Vascepa)
B) Niacin
C) Gemfibrozil
D) Bempedoic acid
A) Use it when LDL is controlled and TG is 150-499 mg/dL.
Case: A patient on a statin needs a fibrate for TG control. Which fibrate is preferred?
A) Gemfibrozil
B) Fenofibrate
C) Niacin
D) High-dose fish oil
B) Gemfibrozil carries a higher myopathy risk when combined with a statin.
Case: 55M with DM on therapy, LDL still above goal despite maximally tolerated statin. Which add-on lowers LDL only, with no meaningful TG or HDL effect?
A) Bempedoic acid
B) Icosapent ethyl
C) Fenofibrate
D) Niacin
A) It lowers LDL only and does not meaningfully lower TG or raise HDL.
Which statin is high intensity (≥50% LDL reduction)?
A) Pravastatin 40 mg
B) Rosuvastatin 20-40 mg
C) Simvastatin 20-40 mg
D) Pitavastatin 4 mg
B) High intensity also includes atorvastatin 40-80 mg. Pravastatin, simvastatin, and pitavastatin are moderate intensity at these doses.
Case: 52M with DM, age 40-75, with at least one ASCVD risk factor, no clinical ASCVD. Which statin plan fits ADA?
A) Moderate intensity, LDL goal <100
B) High intensity, LDL goal <70
C) No statin
D) Low intensity, no LDL goal
B) Dr. Lewis said most patients with DM have hypertension, so most qualify for high intensity.
Case: 70M with prior MI, DM, and multiple high-risk conditions. What LDL goal applies?
A) <100 mg/dL
B) <70 mg/dL
C) <55 mg/dL with ≥50% LDL reduction
D) <40 mg/dL
C) This is very high risk, meaning multiple major ASCVD events or one major event plus multiple high-risk conditions. Not very high risk uses <70 mg/dL.
Case: 62M with DM, no prior ASCVD, age ≥50 with one major risk factor, no bleeding risk, on no antithrombotics. Which antiplatelet approach fits? A) Aspirin is never recommended B) Consider aspirin for primary prevention after weighing risks and benefits C) Clopidogrel 75 mg daily D) Aspirin plus rivaroxaban
B) Consider aspirin for primary prevention after weighing risks and benefits. Age ≥50 with a major risk factor and no increased bleeding risk qualifies, but risks generally outweigh benefits after age 70.
Case: 66M with DM and prior ischemic stroke, on apixaban for atrial fibrillation. Should aspirin be added? A) Yes, for extra protection B) No, dual therapy raises bleeding risk C) Yes, only if A1c is above 8% D) Yes, add clopidogrel
B) No. Do not add aspirin to a patient already on an anticoagulant or antiplatelet, because dual therapy raises bleeding risk.
Case: 60M with DM and prior MI, aspirin allergy. What is the secondary prevention antiplatelet? A) Clopidogrel 75 mg daily B) Aspirin 325 mg daily C) Aspirin 40 mg daily D) Clopidogrel 300 mg daily
A) Clopidogrel 75 mg daily. Aspirin 75-162 mg daily is the first choice for secondary prevention.
Case: Patient with DM and BP 125/76 and albuminuria. Which BP class is first-line when albuminuria is present? A) Thiazide only B) ACE inhibitor or ARB C) Dihydropyridine CCB only D) Verapamil
B) ACE inhibitor or ARB. These are first-line when micro- or macroalbuminuria is present, and they are also used when eGFR is below 60 or hypertension is present.
Case: 67F on a new ACE inhibitor. When should the BMP (SCr, eGFR, K+) be checked? A) Never B) 2-4 weeks after starting and at least annually C) 1 year after starting only D) Daily for 1 week
B) 2-4 weeks after starting and at least annually. Same timing applies to ARBs and diuretics.
Case: 58M on amlodipine asks which dose causes the most peripheral edema. A) 2.5 mg B) 5 mg C) 10 mg D) All doses equally
C) 10 mg. Amlodipine needs no lab monitoring, and edema is more common at 10 mg than at 2.5-5 mg.
Case: 65M with resistant hypertension on first-line agents. What is the next step? A) Spironolactone B) Propranolol C) Verapamil D) Hydrochlorothiazide again
A) Spironolactone. Watch for gynecomastia and hyperkalemia, and check electrolytes within about 1-2 weeks. Hyperkalemia risk is higher with CKD and heart failure.
Case: Nurse measures BP on a patient who just drank coffee and walked into the room. What is the best practice? A) Measure immediately B) Wait 30 minutes after caffeine or exercise, empty bladder, rest 5 minutes C) Measure while the patient talks to you D) Use the same cuff regardless of arm size
B) Wait 30 minutes after caffeine or exercise, empty bladder, rest 5 minutes. Also keep the back supported, feet flat, arm at heart level, and use the correct cuff size.
Case: 60M with DM, microalbuminuria (uACR 88 mg/g). Which category is this? A) Normal B) Microalbuminuria C) Macroalbuminuria D) Proteinuria only
B) Microalbuminuria (30-299 mg/g). Macroalbuminuria is ≥300 mg/g.
Case: Patient with T2DM has an uACR of 88 mg/g and eGFR of 77. Which kidney-protective agent does Dr. Lewis say to use for any albuminuria? A) Metformin B) SGLT-2 inhibitor C) Finerenone only D) Insulin glargine
B) SGLT-2 inhibitor. Consider it for T2DM with eGFR ≥20, even if the glycemic effect is small.
Case: 66M with T2DM and CKD, uACR ≥300 mg/g. Which statement about finerenone (Kerendia) is correct? A) It is steroidal and causes gynecomastia B) It is non-steroidal and does not cause gynecomastia C) It is a loop diuretic D) It is contraindicated with all CYP3A4 drugs
B) It is non-steroidal and does not cause gynecomastia. It is indicated for CKD in T1DM and T2DM and for HFpEF with LVEF ≥40%. It is contraindicated with strong CYP3A4 inhibitors and adrenal insufficiency.
Case: 62M with T2DM and painful peripheral neuropathy and CKD. Which oral agent is the most used in Dr. Lewis's clinic and needs renal dosing? A) Gabapentin B) Amitriptyline C) Lamotrigine D) Valproic acid
A) Gabapentin (900-3,600 mg daily). Counsel on sedation and renally adjust it. Duloxetine is the other common FDA-approved choice.
Case: Clinic nurse performing a foot exam on a patient with T2DM. Which test is most likely used in clinic? A) Ankle reflexes B) Pinprick sensation C) 10-g monofilament D) Temperature sensation
C) 10-g monofilament. Dr. Lewis said this is the tool you will most likely see in clinic. It tests protective sensation.
Case: 70M with T2DM and symptomatic orthostatic hypotension. Which FDA-approved agent treats this? A) Midodrine B) Metoclopramide C) Sildenafil D) Pramlintide
A) Midodrine. Droxidopa is the other FDA-approved choice. Metoclopramide treats gastroparesis, and PDE-5 inhibitors treat erectile dysfunction.
Case: 58M with T2DM and gastroparesis symptoms (early satiety, nausea, weight loss) on a GLP-1 RA. What do you do? A) GLP-1 RA is absolutely contraindicated, stop it permanently B) Continue unchanged regardless of symptoms C) Stop the GLP-1 RA if nausea, bloating, vomiting, or indigestion worsens D) Switch to pramlintide
C) Stop the GLP-1 RA if symptoms worsen. ⚠️ The slide lists GLP-1 RAs under medications to avoid, but Dr. Lewis said they are not absolutely contraindicated. The exam may follow the slide, so know both versions.
Case: Patient with T2DM on oral semaglutide and levothyroxine, both taken on an empty stomach. What is the best instruction? A) Take both together with breakfast B) Take the most important drug first, wait 30 minutes, then take the other C) Take both at bedtime D) Take with a full glass of milk
B) Take the most important drug first, wait 30 minutes, then take the other. Oral semaglutide must be taken on an empty stomach.
Case: Patient with DM on an SGLT-2 inhibitor is scheduled for surgery. When should the drug be stopped? A) Continue through surgery B) Stop 3-4 days before surgery C) Stop 1 day after surgery D) Stop only if glucose is below 70
B) Stop 3-4 days before surgery. This prevents euglycemic DKA risk. Patients may also have higher hematocrit and genital or urinary infections.
Case: Patient with DM starts a GLP-1 RA and reports GI upset. Which counseling point is most helpful? A) Eat one large meal daily B) Stay hydrated, eat small meals often, and avoid greasy foods C) Take the drug with alcohol to reduce nausea D) Stop the drug after 1 week
B) Stay hydrated, eat small meals often, and avoid greasy foods. GI upset is the most common GLP-1 RA problem.
Case: Patient with DM has triglycerides above 500 mg/dL. What should you ask first? A) Fish intake only B) Diabetes control and alcohol use C) Thyroid function only D) Sleep apnea
B) Diabetes control and alcohol use. These are the two main causes. If neither applies, check A1c for undiagnosed diabetes.
Case: Patient is told to limit sodium to 2,300 mg daily. How much table salt is that? A) 1/2 teaspoon B) 1 teaspoon C) 2 teaspoons D) 1 tablespoon
B) 1 teaspoon. Teach patients to avoid added salt, processed and canned foods, frozen meals with sauces, and to rinse canned vegetables.
Case: 64M with T2DM asks about the foot care routine. Which instruction is correct? A) Walk barefoot indoors to strengthen the feet B) Inspect the feet weekly C) Apply lotion between the toes D) Wear clean, soft socks that fit and keep feet warm and dry
D) Wear clean, soft socks that fit and keep feet warm and dry. Never walk barefoot, inspect feet every day, and moisturize skin but not between the toes.
Case: 55M with T2DM, LDL ≥100 and a PREVENT 10-year ASCVD risk of ≥10%. Which LDL goal applies? A) <100 mg/dL B) <70 mg/dL with maximally tolerated statin ± ezetimibe or PCSK9 mAb C) <55 mg/dL D) <130 mg/dL
B) <70 mg/dL with maximally tolerated statin ± ezetimibe or PCSK9 mAb. Dr. Lewis said you need to know the statin intensity and LDL goal, but she will not test non-HDL or ApoB goals.
Case: 45F with T2DM, age 30 to 50s, no complications, long life expectancy. What A1c goal is recommended? A) <6.5% B) <7% C) <8% D) <9%
A) <6.5%. Dr. Lewis's target for younger patients without complications who have a long life expectancy. For most nonpregnant adults the goal is <7%, and <8% applies to very sick patients.
Case: 75F with T2DM and frailty and poor prognosis. What A1c goal avoids hypoglycemia? A) <6.5% B) <7% C) <8% D) <9%
C) <8%. This avoids hypoglycemia in very sick patients or those with poor prognosis.
Case: 60M with T2DM and a family history of premature ASCVD. Which PREVENT calculator selection is correct? A) Heart failure option B) ASCVD option C) Stroke option D) Kidney option
B) ASCVD option. Dr. Lewis said to calculate the PREVENT score for every patient with diabetes and to select the ASCVD calculator, not the heart failure option.
Case: 66F with T2DM and ASCVD. Which dose range is correct for daily aspirin in secondary prevention? A) 75-162 mg B) 325-500 mg C) 20-40 mg D) 500-1,000 mg
A) 75-162 mg daily.
Case: 45M with T2DM and retinopathy present. How often should the ADA recommend a retinal exam? A) Every 1-2 years B) Annually C) Every 5 years D) Only at diagnosis
B) Annually. ⚠️ If retinopathy is absent, the ADA interval is every 1-2 years. Dr. Lewis's clinic practice is a yearly eye exam for everyone, so know both.
Case: Patient with DM and a vision change after starting a GLP-1 RA. What is the best explanation? A) GLP-1 RAs cause retinopathy B) The body adjusting to lower glucose, and any link is correlation, not causation C) Pramlintide reaction D) Hypoglycemia from metformin
B) The body adjusting to lower glucose. Retinopathy is linked to diabetes itself, so any association with GLP-1 RAs is a correlation.
Case: Patient with T2DM and macular edema. Which referral and treatment fit? A) Ophthalmology referral, with intravitreal VEGF inhibitor B) Primary care monitoring only C) Oral gabapentin D) Dietary change alone
A) Ophthalmology referral with intravitreal VEGF inhibitor such as bevacizumab, ranibizumab, or aflibercept. Refer for macular edema, severe non-proliferative retinopathy, or proliferative retinopathy.
Case: Patient with T2DM has pneumococcal vaccine history unknown, age 55. Which regimen fits with no prior history? A) PPSV23 alone B) PCV15 followed by PPSV23 at least 1 year later, or PCV20 alone C) PCV13 alone D) Tdap
B) PCV15 followed by PPSV23 at least 1 year later, or PCV20 alone. Dr. Lewis said PCV20 or PCV21 per her preference.
Case: 55M with T2DM asks about shingles vaccine. Which schedule is correct? A) One dose only B) Two doses 2-6 months apart C) Three doses at 0, 1, and 6 months D) Not recommended
B) Two doses 2-6 months apart. Recommended for ages ≥50, or 18-49 if immunocompromised, and also after a shingles episode.
Case: 62M with T2DM asks about RSV vaccine. Which statement is correct? A) Not recommended with diabetes B) One dose now, and more may be needed later C) Two doses 6 months apart D) Annually
B) One dose now, and more may be needed later. Ages ≥75, or 50-74 with increased risk, and diabetes counts as increased risk.
Case: Patient with DM and an HPV vaccine question, age 30. Which schedule is correct? A) One dose only B) Two doses 6 months apart C) Three doses at 0, 1-2, and 6 months D) Annual dose
C) Three doses at 0, 1-2, and 6 months with Gardasil-9. Ages 9-26 are routine, and 27-45 is discussed with the provider.
Case: Patient with DM has A1c at goal. How often should A1c be checked? A) Every 3 months B) Every 6 months C) Annually D) Only at diagnosis
B) Every 6 months. Check every 3 months if uncontrolled.
Case: Patient with T2DM on metformin for years, no B12 check on record. Which lab should be checked periodically? A) B12 B) Potassium C) Magnesium D) Lipase
A) B12. Check periodically because metformin lowers B12.
Case: Patient with DM on lisinopril asks when to repeat labs. What is the correct answer? A) Never, the drug is safe B) 2-4 weeks after starting, then at least annually C) Only if symptoms develop D) Every 6 months forever
B) 2-4 weeks after starting, then at least annually. Dr. Lewis said to recheck labs in one batch, around 3 months, rather than drawing at 4 weeks and again at 3 months.
Case: Dr. Lewis's four buckets for every DM patient include which set? A) Diabetes control, lipids, blood pressure, and immunizations B) Diet, exercise, sleep, and stress C) Vision, kidney, nerves, and feet D) Statins, aspirin, insulin, and vaccines
A) Diabetes control, lipids, blood pressure, and immunizations. Address all four for every patient.
In the ABCDE prevention mnemonic, which letter stands for cholesterol management? A) A B) B C) C D) D E) E
C) C. A is A1c control and antiplatelet therapy, B is blood pressure, C is cholesterol, D is diet, and E is exercise.
Case: Patient with DM wants to lose weight. He is overweight. What weight loss target does Dr. Lewis cite? A) ≥3% B) ≥5% C) ≥7% D) ≥10%
C) ≥7%. This is a key target for overweight or obese patients with DM.
Case: 58M with DM asks about exercise. Which recommendation fits the guideline? A) 30 minutes once a month B) ≥150 minutes per week of moderate aerobic activity, spread over at least 3 days C) 60 minutes daily of weights only D) No exercise until A1c is at goal
B) ≥150 minutes per week of moderate aerobic activity, spread over at least 3 days.
Case: Patient asks about alcohol limits with DM. What is correct? A) Women ≤1 drink/day, men ≤2 drinks/day B) Women ≤2 drinks/day, men ≤3 drinks/day C) No alcohol D) Women ≤3 drinks/day, men ≤4 drinks/day
A) Women ≤1 drink/day, men ≤2 drinks/day.
Case: Patient with DM asks about fruit. Which is the best recommendation? A) Eat unlimited fruit B) Half an apple or half a banana at a time, and berries have the least sugar C) Avoid all fruit D) Only fruit juice
B) Half an apple or half a banana at a time, and berries have the least sugar and the most antioxidants.
Case: Patient asks about the DASH or Mediterranean diet. Which counseling approach did Dr. Lewis recommend? A) Explain in abstract terms B) Explain with concrete foods such as lean protein, fish, vegetables, and whole grains, with limited bread, pasta, potatoes, and chips C) Tell the patient to avoid all carbohydrates D) Give a printed chart only
B) Explain with concrete foods, including lean protein, fish, vegetables, and whole grains, with limited bread, pasta, potatoes, and chips.
Case: Patient on an SGLT-2 inhibitor develops a urinary infection. Which SGLT-2 side effect does this reflect? A) Genital and urinary tract infections B) Hypoglycemia C) Gastroparesis D) Hyperkalemia
A) Genital and urinary tract infections. Also counsel on dehydration and stop before surgery.
Case: 52F with DM on an SGLT-2 inhibitor has rising hematocrit. Which effect explains this? A) Hemolysis B) Higher hematocrit, a known effect of SGLT-2 inhibitors C) Bone marrow suppression D) Iron deficiency
B) Higher hematocrit, a known effect of SGLT-2 inhibitors per Dr. Lewis.
Case: Patient with DM and a low eGFR starts an SGLT-2 inhibitor for glucose control. What is the expected glucose effect? A) Large glucose lowering B) Small glucose effect, and the drug is used for kidney and CV benefit C) Glucose rises D) No effect
B) Small glucose effect. Dr. Lewis said to use SGLT-2 inhibitors for their kidney and cardiovascular benefit.
Case: Patient on an ACE inhibitor has potassium 5.6 and eGFR 45. Which factor raises hyperkalemia risk? A) Young age B) CKD C) Low sodium diet D) Daily exercise
B) CKD. Hyperkalemia risk is higher with CKD and heart failure, especially on spironolactone.
Case: 60M with DM and T2DM with gastric symptoms, which drug is FDA-approved for gastroparesis? A) Metoclopramide B) Midodrine C) Sildenafil D) Droxidopa
A) Metoclopramide. Midodrine and droxidopa treat orthostatic hypotension.
Case: 70M with DM and erectile dysfunction. Which class is FDA-approved for symptoms? A) PDE-5 inhibitors B) Gabapentinoids C) SNRIs D) Biguanides
A) PDE-5 inhibitors.
Case: Patient asks about natural neuropathy support. Which OTC option does Dr. Lewis mention? A) Alpha-lipoic acid B) Melatonin C) Ginkgo D) Vitamin D only
A) Alpha-lipoic acid. Better glucose control may also reduce the need for drugs.
Case: Patient with DM and T1DM asks when to start neuropathy screening. What is the answer? A) At diagnosis only B) Within 5 years of diagnosis, then annually C) After 10 years of diagnosis D) Never
B) Within 5 years of diagnosis, then annually for T1DM. For T2DM, screen at diagnosis, then annually.
Case: 58F with DM asks what the first-line pain drug class is for neuropathy. Which class is also first-line with duloxetine? A) SNRIs B) Benzodiazepines C) Opioids D) Triptans
A) SNRIs. Duloxetine is the other common FDA-approved choice.
Case: 64M with DM has a documented allergy to aspirin and needs an antiplatelet after MI. What do you prescribe? A) Clopidogrel 75 mg daily B) Aspirin 325 mg daily C) Warfarin D) Dipyridamole
A) Clopidogrel 75 mg daily.
Case: 67F with CAD and PAD asks about adding anticoagulation for antiplatelet therapy. Which option fits? A) Aspirin plus low-dose rivaroxaban B) Warfarin alone C) No antiplatelet D) Clopidogrel plus apixaban
A) Aspirin plus low-dose rivaroxaban for CAD or PAD.